Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate the safety and efficacy of pitolisant in Prader-Willi Syndrome, with an open-label extension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• Pitolisant (pitolisant)

Snippet

Sponsor: Harmony Biosciences Management, Inc. | Conditions: Prader-Willi Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-10-22